Persson M - Search Results

1

Dosimetry of 64Cu-DOTA-AE105, a PET tracer for uPAR imaging.

Persson M, El Ali HH, Binderup T, Pfeifer A, Madsen J, Rasmussen P, Kjaer A. Persson M, et al. Nucl Med Biol. 2014 Mar;41(3):290-5. doi: 10.1016/j.nucmedbio.2013.12.007. Epub 2013 Dec 18. Nucl Med Biol. 2014. PMID: 24533988 Free article.

2

68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.

Persson M, Madsen J, Østergaard S, Ploug M, Kjaer A. Persson M, et al. Nucl Med Biol. 2012 May;39(4):560-9. doi: 10.1016/j.nucmedbio.2011.10.011. Epub 2011 Dec 14. Nucl Med Biol. 2012. PMID: 22172391

3

Quantitative PET of human urokinase-type plasminogen activator receptor with 64Cu-DOTA-AE105: implications for visualizing cancer invasion.

Persson M, Madsen J, Østergaard S, Jensen MM, Jørgensen JT, Juhl K, Lehmann C, Ploug M, Kjaer A. Persson M, et al. J Nucl Med. 2012 Jan;53(1):138-45. doi: 10.2967/jnumed.110.083386. J Nucl Med. 2012. PMID: 22213823 Free article.

4

New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts.

Persson M, Rasmussen P, Madsen J, Ploug M, Kjaer A. Persson M, et al. Nucl Med Biol. 2012 Oct;39(7):962-9. doi: 10.1016/j.nucmedbio.2012.05.007. Epub 2012 Jun 26. Nucl Med Biol. 2012. PMID: 22739362

5

High tumor uptake of (64)Cu: implications for molecular imaging of tumor characteristics with copper-based PET tracers.

Jørgensen JT, Persson M, Madsen J, Kjær A. Jørgensen JT, et al. Among authors: persson m. Nucl Med Biol. 2013 Apr;40(3):345-50. doi: 10.1016/j.nucmedbio.2013.01.002. Epub 2013 Feb 6. Nucl Med Biol. 2013. PMID: 23394821

6

First (18)F-labeled ligand for PET imaging of uPAR: in vivo studies in human prostate cancer xenografts.

Persson M, Liu H, Madsen J, Cheng Z, Kjaer A. Persson M, et al. Nucl Med Biol. 2013 Jul;40(5):618-24. doi: 10.1016/j.nucmedbio.2013.03.001. Epub 2013 Apr 18. Nucl Med Biol. 2013. PMID: 23602763 Free PMC article.

7

Urokinase-type plasminogen activator receptor (uPAR) as a promising new imaging target: potential clinical applications.

Persson M, Kjaer A. Persson M, et al. Clin Physiol Funct Imaging. 2013 Sep;33(5):329-37. doi: 10.1111/cpf.12037. Epub 2013 Apr 3. Clin Physiol Funct Imaging. 2013. PMID: 23701192 Free PMC article. Review.

8

Improved PET imaging of uPAR expression using new (64)Cu-labeled cross-bridged peptide ligands: comparative in vitro and in vivo studies.

Persson M, Hosseini M, Madsen J, Jørgensen TJ, Jensen KJ, Kjaer A, Ploug M. Persson M, et al. Theranostics. 2013 Aug 3;3(9):618-32. doi: 10.7150/thno.6810. eCollection 2013. Theranostics. 2013. PMID: 24052804 Free PMC article.

9

uPAR targeted radionuclide therapy with (177)Lu-DOTA-AE105 inhibits dissemination of metastatic prostate cancer.

Persson M, Juhl K, Rasmussen P, Brandt-Larsen M, Madsen J, Ploug M, Kjaer A. Persson M, et al. Mol Pharm. 2014 Aug 4;11(8):2796-806. doi: 10.1021/mp500177c. Epub 2014 Jul 1. Mol Pharm. 2014. PMID: 24955765

10

Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma.

Persson M, Nedergaard MK, Brandt-Larsen M, Skovgaard D, Jørgensen JT, Michaelsen SR, Madsen J, Lassen U, Poulsen HS, Kjaer A. Persson M, et al. J Nucl Med. 2016 Feb;57(2):272-8. doi: 10.2967/jnumed.115.161703. Epub 2015 Oct 1. J Nucl Med. 2016. PMID: 26429955 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,185 results

Search Page

Filters